Jaguar Health, Inc. (JAGX) Financials
JAGX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 50.8 million | 45.9 million |
| 2023-12-31 | ? | ? |
| 2023-09-30 | 45.4 million | 44.0 million |
| 2023-06-30 | 52.2 million | 46.3 million |
JAGX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | -7.5 million | 582000 |
| 2023-12-31 | ? | ? |
| 2023-09-30 | -6.8 million | 528000 |
| 2023-06-30 | -9.1 million | 527000 |
JAGX Net Income
No data available :(
JAGX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 6.5 million | - | - |
| 2023-12-31 | - | - | - |
| 2023-09-30 | 3.2 million | - | 877000 |
| 2023-06-30 | 8.6 million | - | 1.0 million |
JAGX Shares Outstanding
JAGX Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | - | 3.5 million | 3.5 million | 1.5 million |
| 2023-12-31 | - | - | - | - |
| 2023-09-30 | - | 6.1 million | 4.4 million | 637000 |
| 2023-06-30 | - | 4.3 million | 5.1 million | 878000 |
JAGX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 2.3 million | 1.3 million |
| 2023-12-31 | - | - |
| 2023-09-30 | 2.8 million | 514000 |
| 2023-06-30 | 2.7 million | 491000 |
JAGX
Price: $0.26
52 week price:
Earnings Per Share: -1.79 USD
P/E Ratio: -0.11
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 617552
Ebitda: -16.5 millionMarket Capitalization: 73.3 million